00

Tus Pharmaceutical Group Co Ltd

000590 · SHE · Healthcare / Drug Manufacturers - Specialty & Generic

7.80CNY-0.13 (-1.64%)

Price History

Full chart

Market Stats

Previous Close7.93
Open7.95
Day Range7.77 – 8.06
52-Week Range7.47 – 12.90
Volume2.85M
Market Cap2.18B
P/E (TTM)0.00
Forward P/E32.15
EPS-0.20
Dividend Yield0.00%
Beta0.22
50-Day Avg8.90
200-Day Avg10.39

About

Guhan Pharmaceutical Group Co., Ltd., together with its subsidiaries, manufactures and sells traditional Chinese medicines, chemical drugs, and health food under the Guhan brand in China. It operates through the Pharmaceutical and Health Product Manufacturing and Sales Business, Active Pharmaceutical Ingredient (API) Manufacturing and Sales Business, and Other Business segments. The company offers prescription and over-the-counter drugs, such as tonics, cardiovascular drugs, children's nutritional supplements, cold and flu remedies, and heat-clearing and detoxifying drugs. It also engages in nutrition and health consulting services; Chinese herbal medicine cultivation; medical research and experimental development; cultural and artistic exchange planning; medical consultation; internet sales; technology promotion, consulting, and agency services; outpatient services; and pharmaceutical wholesale and retail activities. The company was formerly known as Tus-Pharmaceutical Group Co., Ltd. and changed its name to Guhan Pharmaceutical Group Co., Ltd. in November 2025. Guhan Pharmaceutical Group Co., Ltd. was founded in 1956 and is headquartered in Hengyang, China.

Company Details

  • SectorHealthcare
  • IndustryDrug Manufacturers - Specialty & Generic
  • CEOMs. Ting Tang
  • Employees1.06K
  • HeadquartersHeadquarters Office Building, Hengyang, China, 421001, China
  • Websitehttps://guhan.com

Leadership

  • Ms. Ting TangVP, CFO & Non Independent Director · b. 1978
  • Mr. Lijun YanBoard Secretary · b. 1971
  • Mr. Ge WenVice President · b. 1973
  • Mr. Chengliang LiuVice President · b. 1969
  • Qian ZhuAccounting Supervisor

Financials

Income Statement

Currency: CNY1992-12-311993-12-311994-12-311995-12-311996-12-311997-12-311998-12-311999-12-312000-12-312001-12-312002-12-312003-12-312004-12-312005-12-312006-12-312007-12-312008-12-312009-12-312010-12-312011-12-312012-12-312013-12-312014-12-312015-12-312016-12-312017-12-312018-12-312019-12-312020-12-312021-12-312022-12-312023-12-312024-12-312025-12-31
Total Revenue32.35M62.68M74.62M93.85M69.06M133.90M198.33M219.63M283.56M245.68M296.61M238.17M267.09M271.11M286.82M207.91M236.57M274.09M311.62M343.51M363.42M256.00M203.12M294.72M301.46M292.87M185.81M315.03M275.09M300.77M350.53M404.65M343.21M337.67M
Growth (%)-+93.78%+19.05%+25.77%-26.42%+93.90%+48.11%+10.74%+29.11%-13.36%+20.73%-19.70%+12.14%+1.51%+5.80%-27.51%+13.79%+15.86%+13.69%+10.23%+5.80%-29.56%-20.66%+45.09%+2.29%-2.85%-36.55%+69.55%-12.68%+9.34%+16.54%+15.44%-15.18%-1.61%
Cost of Revenue21.34M37.58M43.01M54.05M36.38M74.32M113.59M107.83M139.73M151.27M187.83M140.45M137.87M139.30M181.94M101.15M115.89M131.01M133.71M150.25M177.95M144.87M98.77M134.82M119.29M69.84M99.40M148.49M122.25M134.68M172.22M193.41M183.33M186.56M
Gross Profit11.01M25.10M31.61M39.80M32.68M59.59M84.73M111.80M143.83M94.41M108.77M97.71M129.22M131.81M104.89M106.75M120.68M143.08M177.91M193.26M185.47M111.13M104.35M159.90M182.18M223.02M86.42M166.55M152.84M166.09M178.31M211.24M159.87M151.11M
Gross Margin34.03%40.05%42.36%42.40%47.32%44.50%42.72%50.90%50.72%38.43%36.67%41.03%48.38%48.62%36.57%51.35%51.01%52.20%57.09%56.26%51.03%43.41%51.37%54.26%60.43%76.15%46.51%52.87%55.56%55.22%50.87%52.20%46.58%44.75%
Operating Expense7.74M15.83M15.26M19.67M13.80M30.75M58.65M96.84M106.66M156.53M110.72M121.91M126.32M128.84M102.54M71.44M98.08M214.84M116.22M109.05M138.33M239.60M174.17M130.76M118.51M200.71M121.70M114.44M125.05M123.74M155.64M191.08M328.55M169.87M
Operating Income3.26M9.27M16.35M20.12M18.88M28.84M26.08M14.95M37.17M-62.11M-1.95M-24.20M2.90M2.98M2.35M35.32M22.60M-71.76M61.70M84.21M47.14M-128.47M-69.82M29.14M63.67M22.32M-35.28M52.10M27.79M42.35M22.67M20.16M-168.68M-18.76M
Operating Margin10.09%14.79%21.91%21.44%27.33%21.53%13.15%6.81%13.11%-25.28%-0.66%-10.16%1.09%1.10%0.82%16.99%9.55%-26.18%19.80%24.52%12.97%-50.18%-34.37%9.89%21.12%7.62%-18.99%16.54%10.10%14.08%6.47%4.98%-49.15%-5.56%
EBITDA3.96M10.88M17.59M21.29M15.04M29.59M37.30M33.06M38.39M-39.34M33.02M9.46M45.47M45.50M47.01M64.93M53.50M-51.68M77.74M108.17M204.22M-148.38M-70.85M49.15M100.67M67.87M-18.34M69.56M41.83M59.03M44.53M59.46M-92.43M-14.07M
EBITDA Margin12.24%17.35%23.57%22.69%21.78%22.10%18.81%15.05%13.54%-16.01%11.13%3.97%17.02%16.78%16.39%31.23%22.62%-18.86%24.95%31.49%56.19%-57.96%-34.88%16.68%33.39%23.18%-9.87%22.08%15.21%19.63%12.70%14.69%-26.93%-4.17%
Net Income2.60M8.06M15.00M13.45M15.63M24.13M27.87M12.46M30.33M-59.67M4.10M-26.24M5.43M4.29M2.89M20.52M20.37M-88.17M47.15M72.13M137.61M-164.45M-85.77M22.37M55.18M19.17M-38.18M42.44M22.72M35.44M18.11M25.25M-125.47M-50.52M
Net Income Margin8.05%12.86%20.10%14.33%22.63%18.02%14.05%5.67%10.70%-24.29%1.38%-11.02%2.03%1.58%1.01%9.87%8.61%-32.17%15.13%21.00%37.86%-64.24%-42.23%7.59%18.30%6.55%-20.55%13.47%8.26%11.78%5.17%6.24%-36.56%-14.96%
R&D------------------1.92M3.53M2.30M2.61M4.37M4.81M5.95M5.53M7.48M9.46M9.59M8.29M13.10M12.82M13.17M13.91M
R&D as % of Total Revenue------------------0.61%1.03%0.63%1.02%2.15%1.63%1.97%1.89%4.03%3.00%3.49%2.76%3.74%3.17%3.84%4.12%
Interest Expense696.30K1.77M1.96M1.78M34.45K2.36M6.72M8.16M7.09M11.30M14.99M14.62M16.29M17.90M20.61M14.49M13.63M10.50M8.03M5.21M3.18M374.53K3.63M4.25M2.88M740.79K1.59M1.78M113.81K568.03K1.24M4.58M3.75M3.39M
Interest Expense % of Total Revenue2.15%2.83%2.63%1.90%0.05%1.76%3.39%3.72%2.50%4.60%5.05%6.14%6.10%6.60%7.19%6.97%5.76%3.83%2.58%1.52%0.88%0.15%1.79%1.44%0.96%0.25%0.86%0.56%0.04%0.19%0.35%1.13%1.09%1.00%

Balance Sheet

Currency: CNY1992-12-311993-12-311994-12-311995-12-311996-12-311997-12-311998-12-311999-12-312000-12-312001-12-312002-12-312003-12-312004-12-312005-12-312006-12-312007-12-312008-12-312009-12-312010-12-312011-12-312012-12-312013-12-312014-12-312015-12-312016-12-312017-12-312018-12-312019-12-312020-12-312021-12-312022-12-312023-12-312024-12-312025-12-31
Total Assets---141.06M187.46M373.15M404.35M596.86M636.26M695.05M724.86M685.16M676.63M664.58M545.36M548.58M571.31M516.33M568.73M602.45M704.02M552.56M586.82M587.43M630.68M873.74M816.60M846.74M892.16M967.83M1.17B1.15B1.01B889.47M
Total Liabilities---75.74M45.54M132.23M135.56M249.06M256.24M416.40M443.96M426.00M409.06M396.04M274.10M241.37M248.53M285.11M289.85M251.62M225.44M283.05M402.71M381.64M366.72M290.40M236.88M224.58M247.27M285.50M464.26M422.92M412.18M339.98M
Total Equity---65.32M141.91M240.92M268.78M347.21M375.29M279.94M283.83M258.46M267.51M269.15M271.30M307.22M322.78M231.22M289.34M361.29M478.58M269.51M184.11M205.79M260.97M583.33M579.72M622.16M644.88M680.32M698.47M723.72M598.25M547.61M
Cash---5.17M14.25M26.39M18.38M53.55M47.03M28.79M41.35M11.23M17.60M38.63M22.71M24.97M16.44M13.94M8.83M27.73M158.87M65.72M47.84M55.84M122.67M124.28M321.35M314.34M342.95M250.68M235.42M189.77M177.29M177.71M
Total Debt---29.91M20.41M58.66M66.94M96.80M109.17M252.51M252.78M272.19M252.31M241.40M153.50M123.85M110.00M115.14M67.74M62.58M--77.52M63.95M78.30M20.00M38.00M-5.00M8.58M133.79M83.07M84.47M-
Net Debt---24.73M6.16M32.28M48.56M43.25M62.14M223.72M211.43M260.96M234.71M202.77M130.78M98.88M93.56M101.20M58.91M34.85M-158.87M-65.72M29.68M8.11M-44.37M-104.28M-283.35M-314.34M-337.95M-242.10M-101.63M-56.08M-92.82M-

Cash Flow

Currency: CNY1998-12-311999-12-312000-12-312001-12-312002-12-312003-12-312004-12-312005-12-312006-12-312007-12-312008-12-312009-12-312010-12-312011-12-312012-12-312013-12-312014-12-312015-12-312016-12-312017-12-312018-12-312019-12-312020-12-312021-12-312022-12-312023-12-312024-12-312025-12-31
Operating Cash Flow3.89M-10.35M8.23M-51.00M94.30M-24.43M48.46M55.96M-23.33M68.04M34.89M34.14M84.98M30.87M19.75M4.12M-50.91M-60.56M-32.51M-89.14M654.24K29.21M51.48M25.20M54.47M-28.39M17.39M28.96M
Investing Cash Flow-13.36M-18.88M-28.54M-69.41M-67.89M-10.89M-6.94M-9.73M11.58M1.06M-19.02M-22.31M-24.63M-22.14M193.83M-55.03M-38.13M31.32M52.03M-193.06M180.53M7.16M-27.73M-115.98M-177.54M4.15M-31.55M-
Financing Cash Flow1.47M64.40M13.80M102.55M-13.84M5.15M-35.19M-25.15M-4.18M-66.93M-35.81M-4.44M-63.95M10.10M-82.39M-45.04M74.00M37.24M47.31M279.08M16.62M-39.38M4.86M-5.81M111.52M-31.51M-3.31M-
Capital Expenditure9.32M15.10M28.68M43.45M68.01M11.13M7.29M15.47M1.10M2.14M13.99M18.87M24.86M22.68M15.28M15.03M87.39M30.14M16.63M23.88M22.59M35.84M33.91M25.88M18.68M22.04M32.10M48.81M
Free Cash Flow-5.43M-25.44M-20.45M-94.45M26.28M-35.56M41.17M40.49M-24.43M65.90M20.89M15.27M60.12M8.18M4.47M-10.91M-138.30M-90.70M-49.15M-113.02M-21.93M-6.63M17.58M-679.27K35.79M-51.43M-14.71M-19.85M
Dividends Paid6.64M8.75M14.25M13.14M14.32M13.67M16.27M15.74M16.02M15.25M10.51M6.42M5.53M3.81M20.81M45.04M3.54M1.71M987.50K1.11M1.38M1.38M139.44K62.79K338.40K4.20M3.47M3.35M
FCF to OCF-139.64%245.91%-248.42%185.19%27.87%145.58%84.95%72.35%104.72%96.85%59.88%44.72%70.74%26.51%22.62%-264.64%271.67%149.76%151.16%126.78%-3352.23%-22.71%34.14%-2.70%65.70%181.13%-84.63%-68.55%
Dividend Paid to FCF-122.37%-34.40%-69.66%-13.91%54.48%-38.45%39.52%38.88%-65.57%23.14%50.30%42.05%9.19%46.62%465.90%-412.87%-2.56%-1.89%-2.01%-0.99%-6.28%-20.83%0.79%-9.24%0.95%-8.16%-23.55%-16.89%

Earnings

Report DateMar 31, 2010Sep 30, 2010Dec 31, 2010Mar 31, 2011Jun 30, 2011Sep 30, 2011Dec 31, 2011Mar 31, 2012Jun 30, 2012Sep 30, 2012Dec 31, 2012Mar 31, 2013Jun 30, 2013Sep 30, 2013Dec 31, 2013Mar 31, 2014Jun 30, 2014Sep 30, 2014Dec 31, 2014Mar 31, 2015Jun 30, 2015Sep 30, 2015Dec 31, 2015Mar 31, 2016Jun 30, 2016Oct 26, 2016Mar 30, 2017Apr 27, 2017Aug 29, 2017Oct 26, 2017Mar 30, 2018Apr 27, 2018Aug 29, 2018Oct 29, 2018Dec 31, 2018Apr 19, 2019Jun 30, 2019Sep 30, 2019Dec 31, 2019Apr 29, 2020Aug 28, 2020Oct 30, 2020Mar 30, 2021Apr 30, 2021Jun 30, 2021Sep 30, 2021Dec 31, 2021Mar 31, 2022Jun 30, 2022Sep 30, 2022Dec 31, 2022Mar 31, 2023Jun 30, 2023Sep 30, 2023Dec 31, 2023Mar 31, 2024Jun 30, 2024Sep 30, 2024Dec 31, 2024Mar 31, 2025Jun 30, 2025Sep 30, 2025Dec 31, 2025Mar 31, 2026Jun 30, 2026
EPS Estimate-----------------------------------------------------------------
EPS Actual-0.010.120.100.090.030.100.100.080.150.020.370.070.01-0.07-0.740.01-0.00-0.00-0.390.050.000.09-0.040.06-0.010.000.190.050.010.000.020.02-0.01-0.06-0.110.040.020.010.100.040.020.020.010.090.040.04-0.020.05-0.000.020.010.03-0.000.000.08-0.03-0.06-0.02-0.41-0.07-0.000.01-0.15-0.03-0.03
Surprise-----------------------------------------------------------------
Timing-------------------------Pre-marketPre-marketAfter-hoursPre-marketPre-marketPre-marketAfter-hoursPre-marketPre-market-Pre-market-----------------------------

Key Statistics & Ratios

Market Cap2.18B
Enterprise Value2.10B
Trailing P/E0.00
Forward P/E32.15
PEG Ratio0.00
Price / Sales6.62
Price / Book4.07
EPS-0.20
Book Value2.22
Revenue (TTM)329.41M
Gross Profit (TTM)142.58M
EBITDA10.91M
Profit Margin-14.67%
Operating Margin-14.47%
Return on Equity-8.55%
Return on Assets-1.18%
Shares Outstanding239.47M
Shares Float124.10M
Beta0.22
Dividend Yield0.00%
Dividend Rate0.00
Payout Ratio0.00%

Dividends

20131×
0.20Jun 21, 2013
20121×
0.09Sep 4, 2012
20001×
0.03May 9, 2000
19971×
0.04Jul 10, 1997
19961×
0.05Jun 26, 1996

Stock Splits

  • Sep 4, 201211:10
  • Aug 31, 200613.5:10
  • May 9, 20001.8:1
  • Jan 7, 19971.25:1
  • Jun 26, 199612:10